nach oben

Drugs

Erschienen in:

01.11.2012 | Review Article

Sublingual vs Oral Immunotherapy for Food Allergy

Identifying the Right Approach

verfasst von: Satya D. Narisety, Dr Corinne A. Keet, M.D, M.S.

Erschienen in: Drugs | Ausgabe 15/2012

Einloggen, um Zugang zu erhalten

Abstract

The incidence of food allergy in developed countries has increased in recent years, escalating the need to find a suitable form of treatment as an alternative to current management, which includes strict avoidance and ready availability of injectable epinephrine (adrenaline). Allergen immunotherapy is currently being studied for use in the treatment of IgE-mediated food allergy to the most common foods, including peanut, tree nut, milk and egg. Two modalities, oral immunotherapy (OIT) and sublingual immunotherapy (SLIT), have shown great promise. Both OIT and SLIT have been able to desensitize subjects to varying degrees, but the two treatment methods differ in doses that can be achieved, duration of treatment, safety profile and ease of use outside the research setting, among other aspects. More research is needed to conclude which mode of treatment is more effective in inducing long-term tolerance with the least amount of serious adverse reactions. However, OIT and SLIT show great promise, and a widespread treatment for food allergy may be within reach.

Boyce J, Assa’ad AH, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. J Allergy Clin Immunol 2010; 126 (6 Suppl.): S1–58PubMedCrossRef

Branum AM, Lukacs SL. Food allergy among U.S. children: trends in prevalence and hospitalizations. NCHS Data Brief 2008 Oct; (10): 1–8PubMed

Sicherer SH, Munoz-Furlong A, Godbold JH, et al. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol 2010; 125 (6): 1322–6PubMedCrossRef

Decker WW, Campbell RL, Manivannan V, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 2008; 122 (6): 1161–5PubMedCrossRef

Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107(1): 191–3PubMedCrossRef

Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001–2006. J Allergy Clin Immunol 2007; 119 (4): 1016–8PubMedCrossRef

Sicherer SH, Sampson HA. Food allergy. J Allergy Clin Immunol 2010; 125 (2): S116–25PubMedCrossRef

Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2011; 127: 18–27PubMedCrossRef

Viswanathan RK, Busse WW. Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analysis. Chest 2012; 141 (5): 1303–14PubMedCrossRef

10.

Oppenheimer JJ, Nelson HS, Bock SA, et al. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 1992; 90 (2): 256–62PubMedCrossRef

11.

Nelson HS, Lahr J, Rule R, et al. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997; 99 (6 Pt 1): 744–51PubMedCrossRef

12.

Allam JP, Stojanovski G, Friedrichs N, et al. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy 2008; 63: 720–7PubMedCrossRef

13.

Chafen JJ, Newberry SJ, Riedl MA, et al. Diagnosing and managing common food allergies: a systematic review. JAMA 2010; 303 (18): 1848–56PubMedCrossRef

14.

Brozek JL, Terracciano L, Hsu J, et al. Oral immunotherapy for IgE-mediated cow’s milk allergy: a systematic review and meta-analysis. Clin Exp Allergy 2012; 42 (3): 363–74PubMedCrossRef

15.

Skripak JM, Matsui EC, Mudd K, et al. The natural history of IgE-mediated cow’s milk allergy. J Allergy Clin Immunol 2007; 120 (5): 1172–7PubMedCrossRef

16.

Savage JH, Matsui EC, Skripak JM, et al. The natural history of egg allergy. J Allergy Clin Immunol 2007; 120 (6): 1413–7PubMedCrossRef

17.

Skolnick HS, Conover-Walker MK, Koerner CB, et al. The natural history of peanut allergy. J Allergy Clin Immunol 2001; 107(2): 367–74PubMedCrossRef

18.

Patriarca G, Nucera E, Roncallo C, et al. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther 2003; 17 (3): 459–65PubMedCrossRef

19.

Meglio P, Bartone E, Plantamura M, et al. A protocol for oral desensitization in children with IgE-mediated cow’s milk allergy. Allergy 2004; 59 (9): 980–7PubMedCrossRef

20.

Staden U, Rolinck-Werninghaus C, Brewe F, et al. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 2007; 62 (11): 1261–9PubMedCrossRef

21.

Buchanan AD, Green TD, Jones SM, et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 2007; 119 (1): 199–205PubMedCrossRef

22.

Longo G, Barbi E, Berti I, et al. Specific oral tolerance induction in children with very severe cow’s milk-induced reactions. J Allergy Clin Immunol 2008; 121 (2): 343–7PubMedCrossRef

23.

Skripak JM, Nash SD, Rowley H, et al. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow’s milk allergy. J Allergy Clin Immunol 2008; 122 (6): 1154–60PubMedCrossRef

24.

Clark AT, Islam S, King Y, et al. Successful oral tolerance induction in severe peanut allergy. Allergy 2009; 64 (8): 1218–20PubMedCrossRef

25.

Jones SM, Pons L, Roberts JL, et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009; 124 (2): 292–300PubMedCrossRef

26.

Blumchen K, Ulbricht H, Staden U, et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010; 126 (1): 83–91PubMedCrossRef

27.

Pajno GB, Caminiti L, Ruggeri P, et al. Oral immunotherapy for cow’s milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study. Ann Allergy Asthma Immunol 2010; 105: 376–81PubMedCrossRef

28.

Martorell A, De la Hoz B, Ibanez MD, et al. Oral desensitization as a useful treatment in 2-year-old children with cow’s milk allergy. Clin Exp Allergy 2011; 41 (9): 1297–304PubMedCrossRef

29.

Garcia Rodriguez R, Urra JM, Feo-Brito F, et al. Oral rush desensitization to egg: efficacy and safety. Clin Exp Allergy 2011; (41): 1289–96PubMedCrossRef

30.

Anagnostau K, Clark A, King Y, et al. Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin Exp Allergy 2011; 41: 1273–81CrossRef

31.

Burks AW, Jones SM, Wood RA, et al. Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 2012; 367: 233–43PubMedCrossRef

32.

Enrique E, Pineda F, Malek T, et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005; 116 (5): 1073–9PubMedCrossRef

33.

De Boissieu D, Dupont C. Sublingual immunotherapy for cow’s milk protein allergy: a preliminary report. Allergy 2006; 61 (10): 1238–9PubMedCrossRef

34.

Fernandez-Rivas M, Garrido FS, Nadal JA, et al. Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy 2009; 64 (6): 876–83PubMedCrossRef

35.

Kim EH, Bird JA, Kulis M, et al. Sublingual immunotherapy for peanut allergy: clinical and immunological evidence of desensitization. J Allergy Clin Immunol 2011; 127 (3): 640–6.e1PubMedCrossRef

36.

Keet CA, Frischmeyer-Guerrerio PA, Thyagarajan A, et al. The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol 2012 Feb; 129 (2): 448–55, 455.e1–5PubMedCrossRef

37.

Narisety SD, Skripak JM, Steele P, et al. Open-label maintenance after milk oral immunotherapy for IgE-mediated cow’s milk allergy. J Allergy Clin Immunol 2009; 124 (3): 610–2PubMedCrossRef

38.

Hofmann AM, Scurlock AM, Jones SM, et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 2009; 124 (2): 286–91. 291 e281–286PubMedCrossRef

39.

Varshney P, Steele PH, Vickery BP, et al. Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol 2009; 124 (6): 1351–2PubMedCrossRef

40.

Mempel M, Rakoski J, Ring J, et al. Severe anaphylaxis to kiwi fruit: immunologic changes related to successful sublingual allergen immunotherapy. J Allergy Clin Immunol 2003; 111 (6): 1406–140PubMedCrossRef

41.

Kerzl R, Simonowa A, Ring J, et al. Life-threatening anaphylaxis to kiwi fruit: protective sublingual allergen immunotherapy effect persists even after discontinuation. J Allergy Clin Immunol 2007; 119 (2): 507–8PubMedCrossRef

42.

Enrique E, Malek T, Pineda F, et al. Sublingual immunotherapy for hazelnut food allergy: a follow-up study. Ann Allergy Asthma Immunol 2008; 100 (3): 283–4PubMedCrossRef

43.

Narisety SD, Keet CA, Guerrerio P, et al. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy [abstract]. J Allergy Clin Immunol 2012 Feb; 129 (2 Suppl.): AB27CrossRef

Titel: Sublingual vs Oral Immunotherapy for Food Allergy
Identifying the Right Approach
verfasst von: Satya D. Narisety
Dr Corinne A. Keet, M.D, M.S.
Publikationsdatum: 01.11.2012
Verlag: Springer International Publishing
Erschienen in: Drugs / Ausgabe 15/2012
Print ISSN: 0012-6667
Elektronische ISSN: 1179-1950
DOI: https://doi.org/10.2165/11640800-000000000-00000

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Sublingual vs Oral Immunotherapy for Food Allergy

Identifying the Right Approach

Abstract

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 15/2012

Comparison of Amoxicillin/Clavulanic Acid High Dose with Cefdinir in the Treatment of Acute Otitis Media

Phentermine and Topiramate Extended Release (Qsymia™)

Ferumoxytol

Aclidinium

Adjuvant Therapy for High-Risk Gastrointestinal Stromal Tumour

Management of Bleeding in Patients Receiving Conventional or New Anticoagulants